OTC:BIOE | Cash Flow Statement | Bio Essence Corp

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30$270,077.00
2026-03-31$205,373.00-$411,970.00$448,147.00
2025-12-31$1.03M$1.24M-$1.27M
2025-09-30$12,998.00
2025-06-30$59,864.00
2025-03-31-$205,752.00-$26,069.00$24,698.00
2024-12-31-$27,563.00$423,066.00-$451,513.00
2024-09-30-$1.2M
2024-06-30-$215,678.00
2024-03-31$133,938.00-$171,613.00$171,636.00
2023-12-31-$193,687.00-$204,094.00$0.00-$87,870.00$291,989.00
2023-09-30-$314,842.00
2023-06-30-$284,515.00
2023-03-31-$178,836.00-$231,723.00$225,588.00
2022-12-31-$213,131.00-$129,283.00-$49,851.00-$5,527.00$140,500.00
2022-09-30-$199,233.00
2022-06-30-$164,193.00
2022-03-31-$233,120.00-$254,475.00$254,397.00
2021-12-31-$90,634.00-$142,565.00$89,847.00-$89,847.00$206,002.00
2021-09-30-$183,037.00
2021-06-30-$163,538.00
2021-03-31-$210,355.00-$158,639.00$9,537.00-$6,837.00$170,409.00
2020-12-31-$89,542.00-$236,726.00$5,748.00-$5,748.00$231,153.00
2020-09-30-$204,705.00
2020-06-30-$184,447.00
2020-03-31-$117,144.00-$58,482.00$52,193.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31$896,197.00$1.57M-$1.57M
2024-12-31-$1.31M$623,865.00-$114.00-$622,494.00
2023-12-31-$971,879.00-$1.03M$3,614.00-$91,484.00$1.11M
2022-12-31-$809,679.00-$703,241.00$3,742.00-$59,120.00$768,320.00
2021-12-31-$647,564.00-$1.29M$119,496.00-$116,796.00$1.41M
2020-12-31-$595,838.00-$732,744.00$7,365.00-$7,365.00$729,273.00